Renaissance Technologies’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.55M Sell
1,454,400
-928,100
-39% -$1.69M ﹤0.01% 1758
2025
Q4
$5.6M Buy
+2,382,500
New +$4.58M 0.01% 1236
2024
Q1
Sell
-3,653
Closed -$32K 3973
2023
Q4
$32K Buy
+3,653
New +$31.9K ﹤0.01% 3523
2022
Q4
Sell
-683
Closed -$51K 4321
2022
Q3
$51K Buy
683
+637
+1,385% +$135K ﹤0.01% 3752
2022
Q2
$14K Buy
46
+18
+64% +$8.67K ﹤0.01% 4148
2022
Q1
$23K Sell
28
-80
-74% -$64.7K ﹤0.01% 3994
2021
Q4
$105K Buy
+108
New +$189K ﹤0.01% 3673
2021
Q3
Sell
-194
Closed -$591K 3740
2021
Q2
$591K Buy
+194
New +$880K ﹤0.01% 2900
2021
Q1
Sell
-37
Closed -$147K 3603
2020
Q4
$147K Sell
37
-21
-36% -$63K ﹤0.01% 3206
2020
Q3
$152K Sell
58
-41
-41% -$131K ﹤0.01% 3158
2020
Q2
$320K Buy
99
+16
+19% +$57.8K ﹤0.01% 3016
2020
Q1
$246K Buy
83
+25
+43% +$108K ﹤0.01% 3040
2019
Q4
$256K Buy
58
+36
+164% +$180K ﹤0.01% 3110
2019
Q3
$165K Buy
22
+20
+1,000% +$279K ﹤0.01% 3190
2019
Q2
$44K Buy
+2
New +$77.6K ﹤0.01% 3464
2019
Q1
Hold
0
3405

Other funds holding PALI

Renaissance Technologies's PALI Position: Q1 2026 in Review

Renaissance Technologies reduced its Palisade Bio (PALI) stake by 39% in Q1 2026, selling an estimated $1.69M and leaving 1,454,400 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1758.

Renaissance Technologies first reported a position in PALI in Q2 2019 and has held it in 15 quarters since. The position peaked at $5.6M in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Renaissance Technologies held 1,454,400 shares of Palisade Bio worth $2.55M as of Q1 2026.
  • Renaissance Technologies sold 928,100 Palisade Bio shares in Q1 2026, an estimated $1.69M.
  • Palisade Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1758 holding.
  • Renaissance Technologies first reported a position in Palisade Bio in Q2 2019 and has held it in 15 quarters since.
  • Renaissance Technologies's Palisade Bio position peaked at $5.6M in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.